Key Takeaways

  • Science Corporation co-founder Max Hodak treats the brain as the only organ that cannot even in principle be transplanted, viewing the rest of the body as replaceable support hardware.
  • The company's Vessel program develops perfusion medicine to tackle the two leading causes of death: cardiovascular disease and cancer that metastasizes to the brain.
  • Science Corporation secured CE mark approval in Europe for PRIMA, a retinal implant that restores functional form vision to blind patients by treating neural pathways as computational circuits.
  • Hodak argues that human skulls already function as vats, connecting the brain to the outside world through a small collection of cranial and spinal nerves.

Your Organs Are Support Characters

Most medical research spends billions trying to patch individual failing tissues. Max Hodak thinks this approach misses the entire point of human identity. When Hodak looks at human biology, he sees exactly one component that defines the person: the brain.

“The thing that makes you you, the only organ that you can't even in principle transplant, is the brain,” Hodak explained. “The heart, pancreas, the liver, the lungs, as far as I'm concerned, they're really support characters. They're there to keep the brain activity interesting and going.”

The implication is blunt. If your liver fails, you replace it. If your heart stops, you swap in a mechanical pump. But if your brain dies, you die with it. Hodak put his personal stakes simply: “I'm going to be ultimately fairly disappointed if I'm murdered by my pancreas.”

This perspective shifts how Science Corporation picks its technical battles. Instead of building drug compounds to slow down chronic organ decay, Hodak focuses on neural interfaces and perfusion systems that isolate and sustain the nervous system directly.

The Skull Is Already a Vat

Popular science fiction treats the idea of a brain in a jar as a distant, dystopian concept. Hodak sees it as an accurate anatomical description of what you are right now.

“We talk about being a brain in a vat, that's what the skull is,” Hodak noted. “The brain is connected to the environment through a small number of wires, the cranial and spinal nerves.”

Once you accept that model, the engineering requirements become clear. The brain requires two things to survive and operate: metabolic support and data input.

Science Corporation attacks both fronts. For input, their PRIMA retinal implant gained CE mark approval in Europe after restoring functional form vision to blind patients. For metabolic support, their Vessel program develops perfusion technology designed to maintain tissue independently of failing organs.

Hodak is targeting the two main biological failure modes that end human lives: “The two leading causes of death though are cardiovascular disease and cancer that metastasized to the brain, and I think both of those are going to be really attackable through this type of work.”

By taking over the vascular and metabolic workload with external perfusion hardware, the company aims to strip away the constant physical risk humans carry. “There's a fragility that we all live under as part of the human condition,” Hodak said. “If we're successful, what will happen is that sense of jeopardy will fade. We will just become much less fragile.”

In the extreme long run, decoupling the brain from fragile organic machinery provides the foundation for humans to adapt to environments beyond Earth, including deep space.

What to Do With This

Audit your company roadmap for false bottlenecks tomorrow morning. List every dependency in your core product, then label each one as either the actual engine or just support scaffolding. If your engineering team is spending 60 percent of their sprint cycles fixing legacy support infrastructure instead of strengthening your core proprietary asset, spin those peripheral layers out to off-the-shelf vendors this quarter.